Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Flouro-Gem as a First Line Treatment of Metastatic Adenocarcinoma of the Pancreas (GEFLUPAN)

NCT04769414 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.

NCT NCT04769414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04769414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Flouro-Gem as a First Line Treatment of Metastatic Adenocarcinoma of the Pancreas (GEFLUPAN)
Lead sponsor
Menoufia University
Phase
Phase 2
Overall status
Completed
Start date
February 20, 2021
Completion date
July 9, 2022
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of pancreas, chemotherapy effect, metastatic pancreatic cancer